Lamivudine
NDC 33342-001, Lamivudine, tablet, film coated, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-001
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090198
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE150 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-001-09 | 33342000109 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-001-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1be30bcc-2d9f-4afc-8f09-adc840b3f2d9NADAC price for package 33342000109
GET /v1/drugs/nadac/33342000109
Use it
Look up 33342-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.